Update on Transcatheter Tricuspid Valve Replacement Therapies

Research output: Contribution to journalReview articlepeer-review

30 Scopus citations


Severe tricuspid regurgitation is relatively common, especially in the elderly, and portends poor survival. Neither medical therapy nor conventional surgery is efficacious for most patients. In contrast, transcatheter tricuspid valve interventions are showing promise to improve quality of life and mortality. Although there is more clinical experience with transcatheter tricuspid valve repair, there are many patients for which repair is either not possible or cannot optimally reduce the severity of tricuspid regurgitation. Transcatheter tricuspid valve replacement is rapidly emerging and may ultimately become the preferred treatment option. In this review, we discuss transcatheter tricuspid valve replacement, analyze the devices in development and in clinical trials, and highlight the advantages and drawbacks of transcatheter tricuspid valve replacement vs. repair.

Original languageEnglish (US)
Article number619558
JournalFrontiers in Cardiovascular Medicine
StatePublished - Feb 15 2021


  • experimental devices
  • structural valvular heart disease
  • transcatheter valve implantation
  • tricuspid regurgitation
  • tricuspid valve replacement

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine


Dive into the research topics of 'Update on Transcatheter Tricuspid Valve Replacement Therapies'. Together they form a unique fingerprint.

Cite this